Lifevantage Corporation LFVN Protandim and TrueScience Product Line — Concentration risk
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Lifevantage Corporation in its filing.
Tagged under the XBRL concept us-gaap:ConcentrationRiskPercentage1.
The official record: Lifevantage Corporation’s 10-K, filed September 4, 2025, on SEC EDGAR. View the filing →
Ask your AI about Lifevantage Corporation's protandim and truescience product line — concentration risk.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifevantage Corporation's protandim and truescience product line — concentration risk?
- Lifevantage Corporation (LFVN) reported protandim and truescience product line — concentration risk of 21.9% in Q2 2025.
- How has Lifevantage Corporation's protandim and truescience product line — concentration risk changed year-over-year?
- Lifevantage Corporation's protandim and truescience product line — concentration risk increased by 9.4% year-over-year, from 20% to 21.9%.
- What is the long-term trend for Lifevantage Corporation's protandim and truescience product line — concentration risk?
- Over 3 years (2022 to 2025), Lifevantage Corporation's protandim and truescience product line — concentration risk has grown at a 4.5% compound annual growth rate (CAGR), from 76.8% to 87.6%.
- What does protandim and truescience product line — concentration risk mean?
- This metric measures the degree of revenue dependency on the Protandim and TrueScience product lines relative to the company's total segment or enterprise revenue. A higher value indicates that a significant portion of financial performance is tied to these specific product offerings, increasing vulnerability to shifts in consumer demand or competitive disruption within these categories. Monitoring this concentration helps investors assess the diversification of the product portfolio and the potential impact of product-specific market volatility.